The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy()

BACKGROUND: There is a great deal of debate about the role of cardiovascular comorbidities and the chronic use of antihypertensive agents (such as ACE-I and ARBs) on mortality on COVID-19 patients. Of note, ACE2 is responsible for the host cell entry of the virus. METHODS: We extracted data on 575 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Antonio, Voza, Giuseppe, Paiardi, Silvia, Teofilo, Francesca Ilaria, Caltagirone, Giuseppe, Pons, Marta Ripoll, Aloise, Monia, Kogan, Maria, Tommasini, Tobia, Savevski, Victor, Stefanini, Giulio, Angelini, Claudio, Ciccarelli, Michele, Badalamenti, Salvatore, De Nalda, Ana Lleo, Aghemo, Alessio, Cecconi, Maurizio, Martinelli Boneschi, Filippo, Voza, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516574/
https://www.ncbi.nlm.nih.gov/pubmed/32980434
http://dx.doi.org/10.1016/j.ijcard.2020.09.062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516574/
https://www.ncbi.nlm.nih.gov/pubmed/32980434
http://dx.doi.org/10.1016/j.ijcard.2020.09.062

Ejemplares similares